Otros posibles beneficios relacionan el probable efecto de las incretinas sobre una mayor supervivencia de las clulas beta, aunque de momento esto solo se ha observado en estudios preclnicos, asimismo en estudios experimentales en animales se ha visto que el GLP-1 podra inhibir la apoptosis de las clulas beta y estimular la proliferacin y diferenciacin de las clulas beta-pancreticas
For instance, a study published in The New England Journal of Medicine found that individuals taking semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to just 2.4% in the placebo group
nh hng n a v x hi v cch i x: Trong lch s v trong th gii thc, c mi tng quan gia mu da v cc kha cnh v a v x hi, quyn li v cch i x
11 Stephens FB, Constantin-Teodosiu D, Laithwaite D, et al
Because now we are not using this medication to make people lose weight, were using it to make patients gain health. This article was first published on January 13, 2024 Every Match
Life Sciences , 54 (5), PL63PL68